This is already my fourth article on the platform about Novo Nordisk ( NVO ), and I really can't say that the stock has performed well this year-quite the opposite, in fact; it has plummeted. However, I believe there isI am an investor who relies on the fundamental aspects of companies. I enjoy being the owner of the world's best businesses with strong long-term projections. To achieve this, I conduct thorough research on the companies I invest in, placing significant importance on the sector, competitive a ...